Article

Daily Medication Pearl: Fosamprenavir Calcium (Lexiva)

Fosamprenavir calcium (Lexiva ) is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.

Medication Pearl of the Day: Fosamprenavir Calcium (Lexiva)

Indication: Fosamprenavir calcium (Lexiva) is an HIV protease inhibitor indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.

Insight:

  • Dosing:Therapy-naive adults, Lexiva 1400 mg twice daily; Lexiva 1400 mg once daily plus ritonavir 200 mg once daily.
  • Dosage forms: 700 mg tablets and 50 mg/mL oral suspension.
  • Adverse events:In adults, the most common adverse reactions (incidence ≥4%) are diarrhea, rash, nausea, vomiting, and headache.
  • Mechanism of action: Fosamprenavir is an antiviral agent.

Source: Lexiva Label (fda.gov)

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Inflammation concept, inflammated human tissues 3d rendering - Image credit: picture-waterfall | stock.adobe.com
Austin Texas | Image credit: Kevin Ruck - stock.adobe.com
Pharmacy Times OPC